1. Home
  2. SES vs OCGN Comparison

SES vs OCGN Comparison

Compare SES & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SES AI Corporation

SES

SES AI Corporation

N/A

Current Price

$0.60

Market Cap

384.1M

ML Signal

N/A

Logo Ocugen Inc.

OCGN

Ocugen Inc.

N/A

Current Price

$1.35

Market Cap

474.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SES
OCGN
Founded
2012
2013
Country
United States
United States
Employees
N/A
116
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
384.1M
474.8M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
SES
OCGN
Price
$0.60
$1.35
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$4.00
$9.75
AVG Volume (30 Days)
19.1M
4.4M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
29.03
N/A
EPS
N/A
N/A
Revenue
$21,000,000.00
N/A
Revenue This Year
$53.90
N/A
Revenue Next Year
$111.26
$1,718.38
P/E Ratio
N/A
N/A
Revenue Growth
929.41
N/A
52 Week Low
$0.49
$0.98
52 Week High
$3.73
$2.73

Technical Indicators

Market Signals
Indicator
SES
OCGN
Relative Strength Index (RSI) 44.22 52.17
Support Level $0.49 $1.30
Resistance Level $0.66 $1.58
Average True Range (ATR) 0.06 0.07
MACD 0.02 0.02
Stochastic Oscillator 49.95 66.67

Price Performance

Historical Comparison
SES
OCGN

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of rechargeable battery technologies and battery materials for Energy Storage Systems (ESS), Urban Air Mobility (UAM), drones, robotics, electric vehicles (EVs), and other applications. For Enery Storage Systems, the company supplies hardware and software solutions with battery health and safety management software powered by its AI-based platform, Molecular Universe. Additionally, it offers battery materials and high-energy and power-density Li-Metal and Li-ion cells, which can be used for drones, UAM, robotics, and EV applications. The company also offers access to Molecular Universe as a software product. Currently, it generates maximum revenue from the development of Li-ion and Li-Metal battery materials as per the client's specifications.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: